In a paper published online on 22 February in the Scientific Journal Neurology, MND researchers announced results of study (45 controls and 54 people with MND) evaluating whether a urine test for the protein 75ECD (p75ECD) could be used for prognostic and disease progression application.
The researchers, including Dr Mary-Louise Rogers from Flinders University, South Australia, found that urinary p75ECD did change over time, increasing as disease progresses and motor function declines, even for people with slowly progressive disease.
You can read the full paper free online here http://dx.doi.org/10.1212/WNL.0000000000003741
